The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
Cancer, Depression
The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
Developing and Testing an Online Pathway from Screening to Treatment for Depression in Oncology: IPath*D (Aim 2)
-
Dartmouth Cancer Center St. Johnsbury, Saint Johnsbury, Vermont, United States, 05819
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Dartmouth-Hitchcock Medical Center,
Paul Barr, Ph.D., PRINCIPAL_INVESTIGATOR, Dartmouth College
2024-12-22